Company / Free Cash Flow per Share
Cytek Biosciences, Inc. Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.07
FY2025
5-year range
-$0.16 / $0.44
FY2021-FY2025
Trend
-140.3%
vs FY2024
Sector context
#119 of 148
Health Care
What the data says
Cytek Biosciences, Inc.'s free cash flow per share of $-0.07 is lower than 80% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 6 years, ranging from $-0.16 in FY2022 to $0.44 in FY2021.
Based on SEC 10-K filings.
-0.07 in FY2025.
Declined from $0.00 to $-0.07 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 148This company -$0.07 Sector average $5.05
▼
-101.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 140.3% year-over-year.
- Ranks #119 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.07 | -140.3% |
| FY2024 | $0.17 | +3392.8% |
| FY2023 | $0.00 | +102.9% |
| FY2022 | -$0.16 | -137.7% |
| FY2021 | $0.44 | +4.3% |
| FY2020 | $0.42 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026